The role of fecal elastase-1 in detecting exocrine pancreatic disease

2011 ◽  
Vol 8 (7) ◽  
pp. 405-415 ◽  
Author(s):  
John S. Leeds ◽  
Kofi Oppong ◽  
David S. Sanders
2001 ◽  
Vol 120 (5) ◽  
pp. A214-A214
Author(s):  
M VENTRUCCI ◽  
V PAOLETTI ◽  
L CORVAGLIA ◽  
M CAPRETTI ◽  
M MIDDONNO ◽  
...  

2012 ◽  
Vol 142 (5) ◽  
pp. S-462 ◽  
Author(s):  
Yazan Abdalla ◽  
Nimah Jamaluddin ◽  
Sean M. Burns ◽  
Samer Alkaade

Pancreatology ◽  
2017 ◽  
Vol 17 (6) ◽  
pp. 867-874 ◽  
Author(s):  
Robert Memba ◽  
Sinead N. Duggan ◽  
Hazel M. Ni Chonchubhair ◽  
Oonagh M. Griffin ◽  
Yasir Bashir ◽  
...  

Enzyme ◽  
1989 ◽  
Vol 42 (2) ◽  
pp. 80-86 ◽  
Author(s):  
C. Fabris ◽  
D. Basso ◽  
L. Benini ◽  
T. Meggiato ◽  
G. Del Favero ◽  
...  

2021 ◽  
Vol 75 (5) ◽  
pp. 417-423
Author(s):  
Ivo Horný ◽  
Tomáš Hucl

Summary: Pancreatic cysts have been detected ever more frequently in recent years due to the advanced and wider use of imaging methods. We find them on CT or MR also in asymptomatic patients who do not have a history of any pancreatic disease. Pancreatic cystic lesions represent a wide range of pathological changes from simple cysts through precancerous lesions to malignant cysts. Accurate dia­gnosis remains difficult despite the combination of clinical status evaluation, imaging findings, and bio­chemical and cytological examination. Molecular bio­logical examination of cyst aspirate obtained by endosonographic examination increases the detection rate of mucinous cysts (KRAS/GNAS/VHL) and cysts with a high risk of malignancy (KRAS/GNAS/p53/PIK3CA/PTEN/CDKN2A/SMAD4) and optimizes therapeutic approach. Larger prospective validation studies are necessary to make this costly and limited method a routine part of clinical practice. Key words: molecular bio­logy – neoplasia – pancreatic cysts


Enzyme ◽  
1986 ◽  
Vol 35 (2) ◽  
pp. 82-86 ◽  
Author(s):  
C. (a) Fabris ◽  
G. (a) Del Favero ◽  
A. (a) Panucci ◽  
M (b) Plebani ◽  
F. (a) Di Mario ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Mazen Shobassy ◽  
Nedaa Husainat ◽  
Abdalaziz Tabash ◽  
Kalpesh Patel ◽  
Hashem B. El-Serag ◽  
...  

Background and Aims. Fecal elastase-1 (FE-1) as a screening test for exocrine pancreatic insufficiency (EPI) is gaining popularity in clinical practice. The role of imaging in patients with FE-1-related suspicion of EPI remains unclear. The aim of this study was to characterize endoscopic ultrasound (EUS) findings for patients with low FE-1. Methods. A retrospective cross-sectional study was performed in 40 patients who had low FE-1 and underwent EUS to evaluate the pancreas. We obtained data on demographic and lifestyle factors, EUS findings, and histopathology results. We compared these variables between patients with FE‐1<100 mcg/g vs. 100-200 mcg/g. Results. Most patients (82.5%) established one or more new diagnoses from EUS. Diagnoses included: definitive chronic pancreatitis (n=29, 72.5%), fatty pancreas (n=9, 22.5%), and pancreatic solid mass or cyst (n=9, 22.5%). Half (n=4) of the solid or cystic lesions were neoplastic. All patients with a solid pancreatic mass also had concurrent chronic pancreatitis. There were no significant differences in EUS findings or demographic or lifestyle factors between groups with FE‐1<100 mcg/g vs. 100-200 mcg/g. Conclusion. Chronic pancreatitis is the most common EUS finding in patients with low FE-1 levels. EUS appears helpful in determining the cause of EPI in most patients with low FE-1 and may detect unsuspected pancreatic neoplasia.


Endoscopy ◽  
1992 ◽  
Vol 24 (01/02) ◽  
pp. 120-124 ◽  
Author(s):  
N. J. Parikh ◽  
J. E. Geenen

Author(s):  
Dannielle Engle ◽  
Hervé Tiriac ◽  
Arnaud Pommier ◽  
Christina Schoepfer ◽  
Brandon Da Silva ◽  
...  
Keyword(s):  

2020 ◽  
Vol 3 (01) ◽  
pp. 099-113
Author(s):  
Ghali Salahia ◽  
Sook Cheng Chin ◽  
Ian Zealley ◽  
Richard D. White

AbstractPancreatic pathologies are varied and wide-ranging, and a multidisciplinary approach is essential for effective diagnosis and management. We describe image-guided percutaneous (nonendoscopic) interventions in the management of pancreatic disease, with emphasis on inflammatory and neoplastic pancreatic pathologies and on the transplanted pancreas. Image-guided treatments for the complications of pancreatitis include percutaneous interventions on simple and complex peripancreatic collections, pseudocysts, and fistulas. Vascular interventions predominantly focus on the treatment of pseudoaneurysms, hemorrhagic pseudocysts, and arteriovenous malformations. Emerging ablative techniques for pancreatic cancer are promising and include percutaneous radiofrequency ablation, microwave ablation, irreversible electroporation, and electrochemotherapy. Image-guided interventions on the transplanted pancreas commonly include percutaneous biopsy and drainage in addition to endovascular treatments of vascular complications.


Sign in / Sign up

Export Citation Format

Share Document